STAR SIX HEALTHCARE INCORPORATED – Trademark Portfolio
Entity Type: 11
STAR SIX HEALTHCARE INCORPORATED holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 31 (Natural Agricultural Products) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include MAVEN and KINDRX. The owner is based in DELRAY BEACH, FL.
1690 S. CONGRESS AVE
SUITE 205B
DELRAY BEACH, FL 33445
Showing of trademarks Trademarks
Trademark Classifications
STAR SIX HEALTHCARE INCORPORATED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does STAR SIX HEALTHCARE INCORPORATED have?
STAR SIX HEALTHCARE INCORPORATED has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 abandoned.
What trademark classes does STAR SIX HEALTHCARE INCORPORATED file in?
STAR SIX HEALTHCARE INCORPORATED files trademarks across 2 Nice Classification classes. The most active classes are Class 31 (Natural Agricultural Products), Class 5 (Pharmaceuticals). Class 31 covers raw and unprocessed agricultural, aquacultural, horticultural and forestry products.
What are STAR SIX HEALTHCARE INCORPORATED's most well-known trademarks?
STAR SIX HEALTHCARE INCORPORATED's registered trademark portfolio includes well-known marks such as MAVEN and KINDRX. These are among 3 currently registered trademarks in the portfolio.
What is STAR SIX HEALTHCARE INCORPORATED's trademark registration success rate?
STAR SIX HEALTHCARE INCORPORATED has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.